- ►vcu.edu [PDF] CL Loprinzi, JW Kugler, JA Sloan, JA … - The Lancet, 2000 - Elsevier Participants were assigned placebo (n=56) or venlafaxine 37·5 mg daily (n=56),
75 mg daily (n=55), or 150 mg daily (n=54). After a baseline assessment week,
patients took the study medication for 4 weeks. All venlafaxine treatment ... Cited by 469 - Related articles - BL Direct - All 6 versions
- ►topalbertadoctors.org [PDF] HD Nelson, KK Vesco, E Haney, R Fu, A Nedrow … - Jama, 2006 - Am Med Assoc You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. Cited by 211 - Related articles - BL Direct - All 8 versions
- ►jcojournal.org JA Sloan, CL Loprinzi, PJ Novotny, DL Barton, … - Journal of Clinical Oncology, 2001 - jcojournal.org PATIENTS AND METHODS: A series of seven different clinical trials that involved
968 patients was used for this work. Reliable and valid definitions of hot flash
intensity were developed from patient-reported descriptions. Concomitant ... Cited by 190 - Related articles - BL Direct - All 8 versions
T Guttuso Jr, R Kurlan, MP McDermott, K … - Obstetrics & Gynecology, 2003 - journals.lww.com RESULTS: After 12 weeks of double-blind treatment, inten- tion-to-treat analysis
showed that gabapentin 900 mg per day was associated with a 45% reduction in hot
flash frequency and a 54% reduction in hot flash composite score (frequency ... Cited by 190 - Related articles - All 7 versions
- ►jcojournal.org CL Van Patten, IA Olivotto, GK Chambers, KA … - Journal of Clinical Oncology, 2002 - jcojournal.org METHODS: A randomized, placebo-controlled, double-blind clinical trial was
conducted in postmenopausal women with moderate hot flashes who were previously
treated for early-stage breast cancer. Women were stratified for tamoxifen ... Cited by 184 - Related articles - BL Direct - All 10 versions
CL Shapiro, A Recht - The New England journal of medicine, 2001 - nejm.highwire.org Women with primary invasive breast cancer receive both local and systemic
treatment. Surgery and radiation therapy are local treatments given to reduce
the risk of recurrent cancer in the breast, chest wall, and regional lymph ... Cited by 186 - Related articles - BL Direct - All 7 versions
V Stearns, L Ullmer, JF Lopez, Y Smith, C … - The Lancet, 2002 - Elsevier Almost every woman and some men will encounter hot flushes during their
lifetime. Despite the prevalence of the symptoms, the pathophysiology of hot
flushes remains unknown. A decline in hormone concentrations might lead to ... Cited by 172 - Related articles - All 8 versions
ML Evans, E Pritts, E Vittinghoff, K McClish, … - Obstetrics & Gynecology, 2005 - journals.lww.com Michele L. Evans, MD, Elizabeth Pritts, MD, Eric Vittinghoff, PhD, MPH, Karen
McClish, Kevin S. Morgan, and Robert B. Jaffe, MD ... OBJECTIVE: To examine the
efficacy of extended-release ven- lafaxine for the treatment of ... Cited by 119 - Related articles - All 4 versions
- ►nih.gov KJ Pandya, GR Morrow, JA Roscoe, H Zhao, JT … - The Lancet, 2005 - Elsevier Evaluable data were available on 371 participants at 4 weeks (119 placebo, 123
gabapentin 300 mg, and 129 gabapentin 900 mg) and 347 at 8 weeks (113 placebo,
114 gabapentin 300 mg, and 120 gabapentin 900 mg). The percentage decreases ... Cited by 115 - Related articles - BL Direct - All 16 versions
